期刊文献+

AMPA受体介导氯胺酮抗抑郁大鼠海马BDNF及TrkB变化 被引量:5

Changes of hippocampal BDNF and TrkB expression during AMPA receptors mediated ketamine-induced antidepressant effect in rats
下载PDF
导出
摘要 目的观察α-氨基-3-羟基-5-甲基-4-异恶唑(AMPA)受体介导氯胺酮抗抑郁过程中大鼠海马脑源性神经营养因子(BDNF)及酪氨酸受体激酶B(TrkB)的表达变化。方法 80只Wistar雄性大鼠随机均分为八组:第一部分包括二甲基亚砜(DMSO)+生理盐水(V1组)、DMSO+氯胺酮(V2组)、AMPA受体阻断剂(NBQX)5mg/kg+氯胺酮(N5组)、NBQX10mg/kg+氯胺酮(N10组);第二部分包括DMSO+酒精+生理盐水(V3组)、DMSO+酒精+氯胺酮(V4组)、AMPA受体激动剂(CX546)1mg/kg+生理盐水(C0组)、CX5461mg/kg+氯胺酮组(C1组)。干预前1d大鼠强迫游泳15min,干预当天分别进行DMSO、NBQX及CX546预处理,30min后给予1ml生理盐水或氯胺酮10mg/kg。第2次给药后30min强迫游泳,记录5min内不动时间,随后取海马组织检测BDNF及TrkB表达。结果与V2组比较,N5组及N10组大鼠强迫游泳不动时间增加,海马BD-NF、TrkB表达减少(P<0.05)。与V4组比较,C1组大鼠强迫游泳不动时间减少,海马BDNF、TrkB表达增加(P<0.05)。结论 AMPA受体介导氯胺酮抗抑郁作用,这可能与海马组织中BDNF和TrkB表达上调有关。 Objective To observe the expression of hippocampal brain-derived neurotrophic factor (BDNF) and tyrosine receptor kinases B (TrkB) during AMPA receptors mediated ketamine-induced antidepressant effect in rats. Methods Eighty male Wistar rats were equally randomized into eight groups: Part 1 including DMSO+saline (group V1), DMSO+ketamine (group V2), AMPA receptor antagonist (NBQX) 5 mg/kg+ketamine (group N5), NBQX 10 mg/kg+ketamine (group N10); Part 2 including DMSO+alcohol+saline (group V3), DMSC.) 2- alcohol -- ketamine (group V4), AMPA receptor agonist (CX546) 1 mg/kg + saline ( group C0 ), CX546 1 mg/kg + ketamine ( group C1 ). One day before administration of drugs, rats were insulted in forced swimming test (FST) for 15 min. At the second day, rats were pretreated 1 ml of DMSO, Nt3QX and CX546, respectively. Thirty minutes after pretreatment, rats were intraperitoneally injected with 1 ml of saline or ketamine 10 mg/kg, respectively. Thirty minutes later after the second administration, 5min of FST was conducted and the immobility time of rats was recorded. Subsequently, the expression of hippocampal BDNF and TrkB were detected. Results Compared with group V2, rats showed significant increase of the ~ immobility time and decrease of the expression of hippocarnpal BDNF and TrkB in groups N5 and N10 (P〈0. 05). Compared with group V4, rats showed significant decrease of the FST immobility time and increase of the expression of hippocampal BDNF and TrkB in group CI(P〈0. 05). Conclusion AMPA receptors mediate the ketamine-induced antidepressant effect, which may be attributed to the changes in the expression of hippocampal BDNF and TrkB.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2011年第11期1101-1103,共3页 Journal of Clinical Anesthesiology
基金 国家自然科学基金(NO.30872424) 全军"十二五"科研面上项目
关键词 氯胺酮 抑郁 AMPA受体 脑源性神经营养因子 酪氨酸受体激酶B 海马 Ketamine Depression AMPA receptor Brain-derived neurotrophic factor Tyrosine receptor kinases B Hippocampus
  • 相关文献

参考文献12

  • 1Garcia I.S, Comim CM, Valvassori SS, et al. Acute adminis tration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32:140-144.
  • 2Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 2010, 329:959 964.
  • 3Farley S, Apazoglou K, Witkin JM, et al. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmaeol, 2010, 13:1207 1218.
  • 4Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl), 1995, 121:66 -72.
  • 5周志强,杨春,杨建军,徐建国.氯胺酮抗抑郁的研究进展[J].临床麻醉学杂志,2011,27(3):305-306. 被引量:18
  • 6Maeng S, Zarate CA Jr, Du J, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-mcthylisoxazole-4-propionic acid receptors. Biol Psychiatry, 15, 63:349- 352.
  • 7Li X, Tizzano JP, Griffey K, et al. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology, 2001, 40:1028- 1033.
  • 8Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry, 2003, 54: 70-75.
  • 9Siuciak JA, Lewis DR, Wiegand SJ, et al. Antidepressant- like effect of brain-derived neurotrophic factor (BDNF). Pharmaeol Biochem Behav, 1997, 56:131-137.
  • 10Bleakman D, Alt A, Witkin JM. AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets, 2007, 6 : 117-126.

二级参考文献21

  • 1Kessler RC,Berglund P,Demler O,et al.The epidemiology of major depressive disorder:results from the National Comorbidity Survey Replication (NCS-R).JAMA,2003,289:3095-3105.
  • 2Nakajima S,Suzuki T,Watanabe K,et al.Accelerating response to antidepressant treatment in depression:a review and clinical suggestions.Prog Neuropsychopharmacol Biol Psychiatry,2010,34:259-264.
  • 3Li N,Lee B,Liu RJ,et al.mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science,2010,329:959-964.
  • 4Machado-Vieira,Salvadore G,Diazgranados N,et al.Ketamine and the next generation of antidepressants with a rapid onset of action.Pharmacol Ther,2009,123:143-150.
  • 5san het Rot M,Collins KA,Murrough JW,et al.Safety and efficacy of repeated-dose intravenous ketamine for treatmentresistant depression.Biol Psychiatry,2010,67:139-145.
  • 6Messer M,Hailer W,Larson P,et al.The use of a series of ketamine infusions in two patients with treatment-resistant depression.J Neuropsychiatry Clin Neurosci,2010,22:442-444.
  • 7Baumbarger P,Muhlhauser M,Yang CR,et al.LY392098,a novel AMPA receptor potentiator:electrophysiological studies in prefrontal cortical neurons.Neuropharmacology,2001,40:992-1002.
  • 8Maeng S,Zarate CA Jr.The role of glutamate in mood disorders:results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.Curr Psychiatry Rep,2007,9:467-474.
  • 9Pandey GN,Ren X,Rizavi HS,et al.Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims.Int J Neuropsychopharmacol,2008,11:1047-1061.
  • 10Castren E.Neurotrophic effects of antidepressant drugs.Curr Opin Pharmacol,2004,4:58-64.

共引文献17

同被引文献46

  • 1任芹,许华.亚麻醉剂量氯胺酮联合多模式镇痛对结直肠癌患者术后疼痛及早期恢复质量的影响[J].宁夏医科大学学报,2013,35(8):868-871. 被引量:7
  • 2Zhou QG, Hu Y, Hua Y, et al. Neuronal nitric oxide syn- thase contributes to chronic stress induced depression by sup- pressing hippocampal neurogenesis. J Neurochem, 2007, 103(5) : 1843-1854.
  • 3Wang D, An SC, Zhang X. Prevention of chronic stress-in- duced depression like behavior by inducible nitric oxide inhibi- tor. Neurosci Lett,2008, 433(1) : 59-64.
  • 4Yang C, Zhou ZQ, Gao ZQ, etal. Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase 3]3, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients. Biol Psychia- try, 2012, 73(12): e35-e36.
  • 5Duman RS, Li N, Liu RJ, et al. Signaling pathways underly- ing the rapid antidepressant actions of ketamine. Neurophar- macology, 2012, 62(1):35-41.
  • 6Gamaro GD, Prediger ME, Lopes J, et al. Fluoxetine alters feeding behavior and leptin levels in chronically-stressed rats. Pharmacol Biochem Behav, 2008, 90(3) : 312-317.
  • 7Yan HC, Cao X, Das M, et al. Behavioral animal models of depression. Neurosci Bull, 2010, 26(4) :327-337.
  • 8Sevgi S, Ozek M, Eroglu L. L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmaeol, 2006, 28 (2): 95-99.
  • 9Suzuki E, Yagi G, Nakaki T, et al. Elevated plasma nitrate levels in depressive states. J Affect Disord, 2001, 63(1-3):221-224.
  • 10Pagnin D,de Queiroz V,Pini S,et al.Efficacy of ECT in depres-sion:a meta-analytic review[J].J ECT,2004,20(1):13-20.

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部